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Schizotypy is the notion that
schizophrenia-like features can form, in
the absence of illness, a temperamental
“type” or personality trait. Both typo-
logical and characterological accounts
were present at the notion’s concep-
tion as, historically, both categorical
(“Kraepelinian”) and dimensional [e.g.,
Kretchmer’s “schizothymic” temperament;
(1)] accounts of psychotic illness have vied
against one another with the former clearly
ascendant in biological psychiatry at least.
Paul Meehl’s influential development of
the categorical account (2) theorized the
“schizotype” as the category as the funda-
mental phenotypic foundation of “true”
schizophrenia. Variants of this model
remain central to theorizing in the North
American tradition at least. The dimen-
sional view, revitalized by Hans Eysenck, is
best represented in contemporary theory
by Gordon Claridge’s “quasi-dimensional”
model (3).
In 1995, Adrian Raine and Todd Lencz
(4) set out some of the theoretical and
conceptual issues in schizotypal personal-
ity research and outlined the “categories
versus dimensions” issue as “perhaps the
most important” of all (p. 5). They sug-
gested pursuing both approaches so as to
see, which is most productive. There is
of course a distinction here between the-
ory and methodology. I aim to argue here
based on four observations of the empiri-
cal literature that aspects of both theoretical
accounts may be valid, and that a diversity
of methods may have utility in the field.
Claridge’s dimensional account postu-
lates underlying dimensionality of risk for
illness with superimposed clinical discon-
tinuities – the schizophrenic “spectrum” of
illnesses. The critical difference between
the two accounts of schizotypy lies in
the non-clinical portion of the phenotype.
In the categorical account, only a por-
tion of phenotypic schizotypy is at gen-
uine elevated risk, the “true” schizotype,
the remainder is pseudophenotypic, super-
ficially mimicking schizotypy but not pos-
sessing true genetic risk: Adrian Raine (5)
termed the latter “pseudo-schizotypal.” In
the dimensional account, by contrast, there
is the possibility of “genuine” schizotypy
possessing a healthy or adaptive outcome
(6); a theme I reprise in my conclusions.
A few years ago (7), I conducted a biblio-
graphic analysis of the schizotypy literature
that evidenced the growing popularity of
empirical research in the field (schizotyp*
OR schizoid* OR psychosis prone*), and
of experimental studies in particular. In
addition, I divided the empirical literature
into psychometric and experimental stud-
ies, and into those taking a categorical and
dimensional approach (based on their sta-
tistical treatment). The major growth in the
literature has been in experimental studies
of which more have taken a dimensional
(e.g., correlational) approach (Figure 1).
Clearly, there are advantages and dis-
advantages to both statistical approaches
and this choice does not necessarily imply a
strong theoretical preference. For example,
most quantitative genetic studies examine
correlations as a matter of course. Con-
versely, studies based on diagnostic proce-
dures usually retain a categorical approach.
Moreover, a minority of studies report both
statistical treatments, often with broadly
commensurate results. Treating schizotypy
variables as continuous variables is per-
haps sometimes preferred as statistical
power in many analyses is likely to exceed
dichotomized treatment. This is especially
the case if the latter takes seriously the tax-
onomic prediction of 10–15% of a general
population sample (arguably a “median
split” is the worst of all possible worlds).
Large samples are required if the truly
taxonomic approach is to be taken in a
multivariate analysis. While this suits some
fields such as quantitative genetics, it is
not suited to others such as brain imag-
ing. On the other hand, a common strat-
egy is to preselect “schizotypal” and “non-
schizotypal” groups via large-scale screen-
ing using a psychometric instrument. This
usefully reduces the number needed to test
experimentally to achieve statistical power.
However, the strategy may or may not
imply testing of a categorical model – it
is also, of course, a strategy of convenience
for testing dimensional differences.
As a consequence of all these consider-
ations, I would argue that while genuine
differences clearly exist between the mod-
els theoretically, these are very rarely tested
against one another genuinely at the empir-
ical level. Evidence can be found (and is
often rehearsed) for both categorical and
dimensional positions – even from the
same dataset. In some ways, this apparent
duality may parallel the famous “wave–
particle” duality of quantum theory that
suggests that both accounts can be “true”
in different ways, and thus seeks to explain
a diverse range of observations. At the
crudest level, one can observe that broad
measurement of trait tendencies tend to
produce continua, and narrow “symptom-
focused” measures lead to categories. I
would like to suggest some important ways
that both may have validity and research
www.frontiersin.org September 2014 | Volume 5 | Article 134 | 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mason The duality of schizotypy
FIGURE 1 | Bibliometrics: dimensional and categorical approaches.
utility (and I do not claim that this is an
exhaustive list).
I am not alone in noticing empirical evi-
dence for both positions (8). From reviews
of the epidemiological evidence of clini-
cal disorders, Linscott and van Os suggest
that there is true continuum to the non-
clinical. Where I differ from their position
is their suggestion that evidence in the gen-
eral population suggests a latent categorical
structure with “two types of people.” This
structure is generally argued for as a result
of attempts to identify a taxon psychome-
trically. However, the statistical issues of
this argument certainly allow for divergent
interpretations: the issue of taxonomet-
rics in schizotypy has been much discussed
with little resolution (e.g., see Personal-
ity and Individual Differences 44:8; 2008).
Where I do agree with their position is
in viewing schizotypy per se as too nar-
row a lens, “psychosis proneness” captures
the variety of traits relevant to psychotic
disorders as a whole.
TRAIT MULTI-DIMENSIONALITY
Regardless of psychometric arguments
about putative taxons, it is likely that some
measures suit one theoretical position bet-
ter than another. Those with “stronger”
symptom-like measures may tend to dis-
continuities, while others offer greater
dimensionality. In addition, even the range
and nature of dimensions of schizotypal
personality are argued over, with per-
haps the broadest consensus concerning
a distinction between positive and nega-
tive schizotypy. Arguably, there are stronger
indications for the taxonomic nature of
negative schizotypal features such as trait
anhedonia [for review see Ref. (9)]. Con-
versely, Edens et al. (10) found “com-
pelling evidence in two studies of a latent
dimensional structure to paranoid traits.”
In general, and perhaps somewhat surpris-
ingly, there is better evidence for the con-
tinuous distribution of “positive” schizo-
typy (e.g., delusional/paranoid ideation
and hallucination proneness) than for
“negative” schizotypy (anhedonia/social
impairment).
THE POTENTIAL UTILITY OF
SCHIZOTYPAL CLUSTERS
In a development of this first point, Suhr
and Spitznagel (11, 12) attempted to over-
come the common inconsistency of neu-
rocognitive findings in schizotypy by clus-
tering schizotypal individuals rather than
studying individual dimensions. Execu-
tive function deficits were selectively seen
in the negative schizotypy cluster; who
were also more often rated neurocogni-
tively impaired. However, a cluster high on
both positive and negative schizotypy had
the most unusual social behavior ratings.
Subsequently, Barrantes-Vidal et al. (13)
similarly advanced evidence that clusters
worked more effectively than dimensions
in predicting neurocognition and neuro-
logical “soft signs.” Arguably, the conflu-
ence of dimensional traits to produce a
“taxon-like” cluster may be best suited
to identifying those with neurocognitive
deficits, and possibly also in other exper-
imental contexts.
THE OPERATION OF DISCONTINUOUS
“STATE-LIKE” PHENOMENA
While personality traits are usually seen
as broadly consistent over time, stress
or other unusual circumstances produce
“state” effects that may possess qualita-
tively different, and thus discontinuous,
features. In this way, traits may pro-
ceed, more or less temporarily, to “symp-
toms” in the absence of a diagnosed syn-
drome. Usually these are probably highly
temporary, but where more persistent or
frequent that they effectively form sub-
syndromal versions of disorders such as
“basic symptoms” captured by the Schizo-
phrenia Proneness Instrument (14). These
sub-syndromal symptoms may be associ-
ated with the more clearly dysfunctional
cognitive, affective, and behavioral features
of schizotypy/schizophrenia. As they can
become quite persistent states, they may
well give the appearance of a taxon.
EPISTATIC MECHANISMS MEDIATING
GENE–ENVIRONMENT INTERACTION
It is increasingly accepted that many indi-
vidual loci each make a very small con-
tribution to overall genetic risk (15). On
prima facie grounds, such evidence sup-
ports the notion of one or more continua
(16, 17) and probably underpins the her-
itability seen for broadly defined schizo-
typal traits. However, there remains the
possibility for individual schizotypal fea-
tures to arise from more specific gene loci,
or more likely from complex gene-gene
and gene-environment interactions. Over-
all, it is difficult to disambiguate contin-
uous from discontinuous genetic effects
from studies of heritability alone. One of
the largest heritability studies to date (18),
albeit with no single standard psychome-
tric scale, suggested a pattern of heritabil-
ity for social anhedonia consistent with a
single dominant gene as postulated in the
Meehlian account. Overall, many heritabil-
ity studies [e.g., Ref. (19)] postulate her-
itability of around 50% with the remain-
der due to non-shared environmental vari-
ance. While the quest for a “schizophrenia
gene” able to discriminate clinical from
non-clinical groups continues with link-
age and genome-wide association stud-
ies, there has been little sustained suc-
cess: Weinberger concluded that results“are
decidedly disappointing to those expecting
this strategy to yield conclusive evidence
of common variants predicting risk for
schizophrenia” [p. 840, Ref. (20)]. A small
number of gene-of-interest (GOI) studies
have nevertheless some consistent results
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largely with positive schizotypy. These con-
cern the polymorphisms of genes rele-
vant to dopamine transmission such as
COMT (16, 21), DRD1 and DRD2 (22),
SLC6A3 (16, 21), or MAOA (16). Such
studies evidence greater schizotypy asso-
ciating with several polymorphisms such
as rs4680 SNP (single nucleotide polymor-
phisms) within the COMT-gene in a con-
tinuous fashion. However, sometimes this
association is only seen in the presence
of an environmental factor such as child-
hood abuse (23). As investigation of these
in detail is in its infancy, it is likely that
much greater specification of their rele-
vance and mode of action will occur in
future studies.
There is also increasing evidence of epi-
genetic action, whereby environmental fac-
tors influence the expression of genes (15,
24). Svarkic et al. [p. 2, Ref. (25)] out-
line a model, whereby “abnormal epige-
netic states with large effects are superim-
posed on a polygenic liability to schizo-
phrenia.” This is effectively an extension
or variant of point 3 and highlights how
the actions of specific genes (individually
making a small quantitative contribution
to risk) may translate into genuinely tax-
onomic discontinuities – but only in the
context of a pathogenic environment.
CONCLUSION
Overall, I have attempted to argue that
even in the non-pathological domain of
schizotypal individual differences there are
numerous possibilities for both dimen-
sional and categorical expressions both of
traits and states. Taxonomic expression has
greater support for negative schizotypal
features such as anhedonia and potentially
some associated neurocognitive features;
positive schizotypy, on the other hand, sees
much empirical support for “true” dimen-
sionality at both genotype and phenotypic
expression. Even here, however, there is
room for gene–environment interactions
and epigenetics to produce discontinuous
results.
As a rider to this final point, it is
apposite to point out that there may
equally be important phenotypic conse-
quences for schizotypy in the absence of
a pathogenic environment or the pres-
ence of a protective factor such as high
cognitive or emotional intelligence. Thus,
positive schizotypy is also associated with
a range of “healthy” or at least adaptive
outcomes. Again, paralleling the advan-
tages seen with cluster analytic approaches,
Tabak and Weisman de Mamani (26) iden-
tified several schizotypal latent profiles:
the negative/disorganized schizotypy pro-
file had the poorest levels of well-being
and schizotypes solely with positive fea-
tures had the highest – commensurate with
non-schizotypes. Taking a similar latent
profile analytic approach to a non-clinical
sample, Hori et al. (27) described 15%
as “high-positive-schizotypy/adaptive” and
possessing of high self-directedness, coop-
erativeness, and self-transcendence. This is
consistent with growing evidence of the
highly creative and spiritual outcomes for
some schizotypal individuals (28, 29), and
may point to the operation of antagonis-
tic pleiotropy or genetic linkage such that
schizotypal traits survived throughout our
evolutionary history (30).
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